Poster
Changes in mast cell numbers and phenotype in patients with indolent systemic mastocytosis treated with avapritinib
Condition
Indolent Systemic Mastocytosis
Source url
s3://convoke-optic-posters/2024-05-10/Blueprint-Medicines-AACR-2021-Avapritinib-Indolent-SM-Poster-1.pdf
8 organizations
1 product
Product
AvapritinibOrganization
University of UtahOrganization
ARUP LaboratoriesOrganization
Charité - Universitätsmedizin BerlinOrganization
University Medical Center GroningenOrganization
Blueprint MedicinesOrganization
Odense University HospitalOrganization
University of Michigan